project id: TCGA-PAAD; case submitter id: TCGA-YH-A8SY; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.53; rna integrity number: 8.5; age at index: 73; days to birth: -26859; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1938; age at diagnosis: 26859; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 388.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Head of pancreas; synchronous malignancy: No; tissue or organ of origin: Head of pancreas; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to collection: 936; initial weight: 720.0; sample id: 80dccacc-f79c-4701-9fa7-77982fe7a9c7; sample submitter id: TCGA-YH-A8SY-01A; portion id: 4da76db3-a8e3-45b3-9ffe-0e7c87d4dc0d; portion submitter id: TCGA-YH-A8SY-01A-11; slide id: 7180eed4-34c2-4b4b-b277-f059919f74dc; slide submitter id: TCGA-YH-A8SY-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 50.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; section location: TOP;